High-grade Astrocytoma

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma [Phase 1]

  A Phase 1 pediatric trial of SurVaxM for progressive or relapsed medulloblastoma, high-grade glioma, ependymoma, and newly diagnosed diffuse…

• CLINICAL_TRIALS trial_result · 2025-02-19
  Clinical Trial Update: INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas [Phase 1]

  Phase 1 trial of INCB7839 in children with recurrent or progressive high-grade gliomas has completed and results have been posted.

• CLINICAL_TRIALS trial_result · 2024-10-10
  Clinical Trial Update: Phase I Study of APX005M in Pediatric Central Nervous System Tumors [Phase 1]

  Phase I study of APX005M in pediatric central nervous system tumors; the trial is active but not recruiting and results have been posted. Sp…

• CLINICAL_TRIALS trial_result · 2023-06-01
  Clinical Trial Update: Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma [Phase 1, Phase 2]

  A Phase I/II trial evaluating TVI-Brain-1 for safety and efficacy in recurrent high-grade gliomas, including glioblastoma multiforme, has co…

• CLINICAL_TRIALS trial_result · 2021-03-30
  Clinical Trial Update: External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas [Phase 2]

  A Phase 2 clinical trial evaluating external beam radiation therapy with cetuximab, followed by irinotecan and cetuximab, in children and yo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.